TYROSINE KINASE INHIBITOR KERATITIS

Course overview

TYROSINE KINASE INHIBITOR (TKI) KERATITIS IS AN OCULAR COMPLICATION OF CERTAIN ANTINEOPLASTIC MEDICATIONS, PRIMARILY THOSE THAT INHIBIT THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR). THIS ACTIVITY WILL FOCUS ON THE ETIOLOGY, EPIDEMIOLOGY, PATHOPHYSIOLOGY, CLINICAL PRESENTATION, AND MANAGEMENT OF TKI KERATITIS. IT ALSO HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN MANAGING PATIENTS WITH THIS CONDITION.